UnitedHealth Group Incorporated (UNH)
NYSE: UNH · Real-Time Price · USD
366.77
+12.08 (3.41%)
At close: Apr 28, 2026, 4:00 PM EDT
364.69
-2.08 (-0.57%)
Pre-market: Apr 29, 2026, 9:01 AM EDT
UnitedHealth Group Stock Forecast
Stock Price Forecast
The 26 analysts with 12-month price forecasts for UnitedHealth Group stock have an average target of 384.5, with a low estimate of 270 and a high estimate of 440. The average target predicts an increase of 4.83% from the current stock price of 366.77.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for UnitedHealth Group stock from 26 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 6 | 6 | 7 | 7 | 7 | 7 |
| Buy | 14 | 14 | 14 | 14 | 14 | 15 |
| Hold | 3 | 3 | 3 | 3 | 3 | 2 |
| Sell | 2 | 2 | 2 | 2 | 2 | 2 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 25 | 25 | 26 | 26 | 26 | 26 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| JP Morgan | JP Morgan | Buy Maintains $389 → $420 | Buy | Maintains | $389 → $420 | +14.51% | Apr 28, 2026 |
| TD Cowen | TD Cowen | Hold Maintains $311 → $337 | Hold | Maintains | $311 → $337 | -8.12% | Apr 23, 2026 |
| Morgan Stanley | Morgan Stanley | Buy Maintains $375 → $395 | Buy | Maintains | $375 → $395 | +7.70% | Apr 22, 2026 |
| Argus Research | Argus Research | Hold → Strong Buy Upgrades $400 | Hold → Strong Buy | Upgrades | $400 | +9.06% | Apr 22, 2026 |
| Wells Fargo | Wells Fargo | Buy Maintains $370 → $397 | Buy | Maintains | $370 → $397 | +8.24% | Apr 22, 2026 |
Financial Forecast
Revenue This Year
445.16B
from 447.57B
Decreased by -0.54%
Revenue Next Year
461.36B
from 445.16B
Increased by 3.64%
EPS This Year
18.03
from 13.23
Increased by 36.28%
EPS Next Year
20.05
from 18.03
Increased by 11.21%
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 467.1B | 499.9B | ||||||
| Avg | 445.2B | 461.4B | ||||||
| Low | 426.3B | 432.4B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 4.4% | 12.3% | ||||||
| Avg | -0.5% | 3.6% | ||||||
| Low | -4.7% | -2.9% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 19.83 | 22.67 | ||||||
| Avg | 18.03 | 20.05 | ||||||
| Low | 17.18 | 15.83 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 49.9% | 25.7% | ||||||
| Avg | 36.3% | 11.2% | ||||||
| Low | 29.9% | -12.2% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.